Loading...

Skip to main content

Call us on + 1 (800) 604-9114 for more information about our products

Looking for specific datasheet Manual/COA/MSDS?
Request a Manual/COA/MSDS

Interested to get a quote about our products?
Request a Quote

Influenza B Virus Tokio 53/99 Native Protein

Influenza B Virus Tokio 53/99

Applications
ELISA
Purity
Greater than 90.0% as determined byAnalysis by SDS-PAGE.
Synonyms
Influenza B Virus Tokio 53/99; Influenza-B Tokio; Influenza-B Virus Tokio/53/99; Tokio 53/99; Influenza B Virus Tokio 53/99 native protein
Ordering
For Research Use Only!
Purity/Purification
Greater than 90.0% as determined byAnalysis by SDS-PAGE.
Form/Format
Sterile Filtered colorless solution.
Applicable Applications for Influenza B Virus Tokio 53/99 native protein
ELISA (EIA)
Application Notes
Immunological Activity: Serological studies of influenza B virus, immunogen for antibody production. Tested with anti-influenza B monoclonal antibodies in ELISA.
Inactivation
Thimerosal and beta propiolactone treatmentThis product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.
Preparation and Storage
B/Tokio/53/99 although stable 4 degree C for 4 weeks, should be stored below -18 degree C. Please prevent freeze-thaw cycles.
Related Product Information for Influenza B Virus Tokio 53/99 native protein
Description: Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Tokio/53/99. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient.

Introduction: Influenza-B virus is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift and reassortment. Influenza-B virus evolves slower than A viruses and faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, and a polymerasecomplex. Influenza B is sometimes spherical and sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin and neuraminidase.The Influenza B virus is 14648 nucleotideslong and consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, and the nucleocapsids are surrounded by one envelope.
Product Categories/Family for Influenza B Virus Tokio 53/99 native protein

Similar Products

Product Notes

The Influenza B Virus Tokio 53/99 (Catalog #AAA142733) is a Native Protein and is intended for research purposes only. The product is available for immediate purchase. AAA Biotech's Influenza B Virus Tokio 53/99 can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA). Immunological Activity: Serological studies of influenza B virus, immunogen for antibody production. Tested with anti-influenza B monoclonal antibodies in ELISA. Researchers should empirically determine the suitability of the Influenza B Virus Tokio 53/99 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "Influenza B Virus Tokio 53/99, Native Protein" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.

Precautions

All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.

Disclaimer

Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.

Item has been added to Shopping Cart

If you are ready to order, navigate to Shopping Cart and get ready to checkout.

Looking for a specific manual?
Request a Manual

Request more Information

Please complete the form below and a representative will contact you as soon as possible.

Request a Manual

Please complete the form below and a representative will contact you as soon as possible.

Request a Quote

Please complete the form below and a representative will contact you as soon as possible.